Consuelo Corti is the Director of the Simple Functional Unit of Day Hospital/MAC/Hematology and Bone Marrow Transplant Clinic of the IRCCS San Raffaele Hospital. After graduating in Medicine and Surgery in 1986 from the State University of Milan, in 1988 she specialized in Internal Medicine, and in 1996 she obtained a diploma in Clinical Oncology from the Faculty of Medicine of Paris South. She deals with hematological patients in their treatment pathways and, in particular, with patients affected by hematological and oncohaematological pathologies, including patients with autologous and allogeneic bone marrow transplant programs and subsequent follow-up, patients included in research protocols (including phase I) and patients with immune effector cell therapy programs (CAR T and gene therapies). Regarding research activity, she mainly deals with infectious disease problems and patients suffering from chronic lymphocytic leukemia. She has been part of the EBMT (European Blood and Marrow Transplantation Group) and the GITMO (Italian Bone Marrow Transplant Group) for years. Since 2007 she has been the Quality Manager of the Hematology and Marrow Transplant department and, since 2008, of the Stem Cell Program at San Raffaele Hospital, which includes the adult and pediatric clinical area, the marrow and peripheral collection unit and the Institutional Tissue Institute.
Jacopo Peccatori is responsible for the Functional Unit of Bone Marrow Transplant and responsible for the Clinical Unit of the Transplant Program (CIC 813), at the Operational Unit of Hematology and Bone Marrow Transplant of the IRCCS San Raffaele Hospital, and collaborates at the La Madonnina nursing home. His training path began in 1993 with a degree in Medicine and Surgery at the University of Milan, where he specialized in Internal Medicine in 1998. He subsequently obtained his specialization in Hematology in 2006 at the University of Milan-Bicocca. Over the years he has carried out training periods abroad, in particular at the pediatric transplant unit of the Great Ormond Street Hospital, in London. He also collaborated with the Cure2Children association for an international transplant development project in India, spending a period in the Jaipur hospital. He has followed various refresher courses on pain management and, for years, has personally performed procedural sedation during diagnostic maneuvers (for example spinal cord aspirate and lumbar punctures) which may otherwise be unpleasant for the patient. He has launched numerous studies on allogeneic transplantation with reduced toxicity and participates in multicenter and international studies on transplantation which have been published in important scientific journals. He is a member of the EBMT (European Blood and Marrow Transplantation Group) and of the GITMO (Italian Bone Marrow Group).
Massimo Puoti, MD, is a Specialist in Gastroenterology and Infectious Disease. From 1988, he served as a consultant in the Department of Infectious Diseases of the AO Spedali Civili of Brescia, Italy, a General Teaching Hospital. From 2005 to 2010, he served as an Associate Professor of Infectious Diseases in the School of Medicine of the University of Brescia. His main fields of research are hepatitis viruses and HIV infections. He has been the Director of the Infectious Diseases Department of the Great Metropolitan Hospital Niguarda in Milan since 2010, and he has been a Professor of Infectious Diseases at the School of Medicine, University of Milano-Bicocca since 2020. He is a member of the European Association for the Study of The Liver (EASL), the European Society of Clinical Microbiology and Infectious Diseases, the Italian Association for the Study of the Liver, the Italian Society for the Study of Infectious and Parasitic Diseases, and the Italian Society for the Study of Sexually Transmitted Diseases. He was a member of the coordinating committee of Associazione Italiana Studio Fegato (the Italian Association for the Study of the Liver) from 2004 to 2007.
Bernardi Massimo has been the deputy director since January 2002, responsible for the in-patients of the Haematology Unit IRCCS Ospedale San Raffaele, where he coordinates a staff of 4 physicians and is involved in the training of medical students. He is committed to the diagnosis and treatment of acute leukemias and myelodysplastic syndromes, and he is involved in several cooperative retrospective and prospective trials which study the relevance of new prognostic factors and treatment strategies, also including new drugs in phase I–III protocols, in these pathologies. He is personally responsible for therapeutic programs for patients with AML and MDS at OSR and he is the principal investigator of an internal protocol of autologous transplantation, with an original conditioning regimen for patients older than 65. He is a member of the following groups and societies: EBMT, EHA, MDS foundation, GITMO, CMWP of EBMT, REL MDS subcommittee, and the REL acute leukemias subcommittee.
Antonella Castagna is a Full Professor at the Clinic of Infectious Diseases, Vita-Salute San Raffaele University and the Head of Infectious Diseases at San Raffaele Scientific Institute. She has a broad background in the management of HIV-1 infected patients and her research has included the control of opportunistic infections and long-term non-HIV complications (cardiovascular risk, cirrhosis, cancer, diabetes) and antiretroviral drugs, the evaluation of new therapeutic strategies aimed at reducing ART toxicity and management of multidrug-resistance as well as the evaluation of clinical implications associated with the occurrence of residual viremia. Her current research interests are in the field of HIV reservoirs and the interventions aimed at reducing these reservoirs. In addition, she has successfully administered several projects funded by national and international agencies, collaborated with other researchers, and produced several peer-reviewed publications from each project. A distinct characteristic of her work is the attention to the “clinical relevance” of the projects to ensure that, where possible, any outputs can be translated into improvements in clinical care.
Fabio Ciceri is the head of the Hematology and Bone Marrow Transplantation Unit. Since 2018, he has been also a full professor of Hematology at the Vita-Salute San Raffaele University, where he directs the school of specialization in Hematology. He is also the current president of GITMO, the Italian Bone Marrow Transplant Group. His research activity has enabled transplantations from partially compatible haploidentical donors as a therapeutic option in high-risk oncohaematological diseases. Since 1996, he has been the Principal Investigator in the clinical development of advanced cell therapy, gene therapy and regenerative medicine programs in both oncological and non-oncological diseases. Among these, he has contributed to the development of the first advanced cell therapy for blood cancer, with the use of the suicide gene HSV-TK for the control of donor lymphocytes, and the development of gene therapies for the treatment of primitive immunodeficiencies, metabolic diseases and beta-thalassemia. He is a member of several organizations, such as the Italian Society of Hematology (SIE), the Lombard Hematological Network (REL), the Italian Group of Adult Hematological Diseases (GIMEMA), the European Blood and Marrow Transplantation Group (EBMTG), the European Hematology Association (EHA), the International Network of Cancer Trial Research (INCTR), the International Cardio Oncology Society (ICOS) and the European Technology Platform for Nanomedicine (ETPN).
Raffaella Greco is a senior Haematologist in the Blood and Marrow Transplant (BMT) Unit at the IRCCS San Raffaele Hospital in Milan, Italy. After graduating in 2008 from the Faculty of Medicine and Surgery of the University of Milan Vita-Salute San Raffaele, she received a specialization in hematology at the same university in 2014. She is currently involved with EBMT as the Autoimmune Diseases Working Party (ADWP) Chair; she is also the Scientific Council Representative with the Education Portfolio and an active member of the Cellular Therapy & Immunobiology Working Party (CTIWP). She has published 111 papers with 2970 citations and an h-index of 31 (Scopus, 18 December 2023). Her research topics mainly include invasive fungal.
